Cleared Traditional

K092258 - RANDOX METABOLITE (EDDP) ASSAY (FDA 510(k) Clearance)

Nov 2010
Decision
469d
Days
Class 2
Risk

K092258 is an FDA 510(k) clearance for the RANDOX METABOLITE (EDDP) ASSAY. This device is classified as a Enzyme Immunoassay, Methadone (Class II - Special Controls, product code DJR).

Submitted by Randox Laboratories, Ltd. (Crumlin, GB). The FDA issued a Cleared decision on November 9, 2010, 469 days after receiving the submission on July 28, 2009.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3620.

Submission Details

510(k) Number K092258 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2009
Decision Date November 09, 2010
Days to Decision 469 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code DJR — Enzyme Immunoassay, Methadone
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3620